Reckitt Benckiser Group PLC

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Johann A. Benckiser in 1823 and is headquartered in Slough, the United Kingdom.

Baxter

Colgate-Palmolive

Con Ed

Hormel Foods

Kellogg

Altria

Novartis

Northwest Natural Gas

Pinnacle West Capital

Unilever

Verizon

The market is 30% overvalued, and September is historically a time when many corrections begin. Fortunately, there are plenty of high-yield/low volatility blue chips to choose from.

14 High-Yield Blue Chips For A Rich Retirement

Amazon

Aspen Technology Inc

Alibaba

Bayer AG

Baidu

British American Tobacco

Anheuser-Busch InBev

Campbell Soup

Enterprise Products Partners

GlaxoSmithKline

Imperial Brands PLC

Intel

Lockheed Martin

Merck

Polaris

Roche Holding AG

Sanofi

Tencent Holdings Limited

Western Union

Yum China Hlds

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.

Wide-Moat Stocks On Sale - The September 2021 Heat Map

Reckitt Benckiser reported weak half-year results and as consequence the stock dropped in the following years. The company will sell its Infant Formula and Child Nutrition business in China, which will strengthen the balance sheet.

Reckitt Benckiser Looks Like A Bargain

PepsiCo

Procter & Gamble

The British consumer-goods giant also said that it is closely watching near-term demand for disinfectants as coronavirus variants spread.

Lysol Maker Reckitt Warns About Inflation. What It Means for P&G and PepsiCo.

Reckitt Benckiser Group plc (LON: RB) tanked nearly 10% in the stock market on Tuesday morning as the consumer goods company said higher costs weighed on its revenue in the fiscal first half. Consequently, it swung to a pre-tax loss in H1.

Here's why Reckitt Benckiser shares are down almost 10% on Tuesday morning

Reckitt PLC shares fell out of bed on Tuesday as the company fell into the black and warned of rising costs. Net revenue in the first half of 2021 dipped to £6.60bn from £6.91bn in the corresponding period of 2020.

Reckitt shares dive as it warns of lower margins

Reckitt Benckiser reports loss as costs rise

Lysol maker Reckitt Benckiser Group missed analysts' estimates for second-quarter sales on Tuesday, as demand eased for its soaps and cold remedies and the company backed its full-year outlook.

Reckitt second-quarter sales miss estimates

AbbVie

Amgen

Gilead Sciences

General Mills

Alphabet

Henkel AG & Co KGaA

Walgreens

The stock market is overvalued, but we can still try to find investments without overpaying. A first category of stocks are recession-proof and undervalued companies like Walgreens Boots Alliance, Henkel, Amgen or AbbVie.

10 Picks For July

The Mead Johnson acquisition has been a disaster so far and the high expectations could never be met.

Reckitt Benckiser Sells Its Problem Child, To Refocus On Its Strengths

U.K. consumer-goods giant Reckitt has struggled for years to make its baby-nutrition unit work in China. That is over now.

Reckitt Finally Unloads China Baby-Food Business in $2.2 Billion Deal

Reckitt Benckiser Group PLC (LON:RB) will book a £2.5bn loss after agreeing the sale of its infant formula and child nutrition business in China to Primavera Capital. Consideration for IFCN China including debt will be US$2.2bn with cash proceeds of US$1.3bn.

Reckitt Benckiser books £2.5bn loss on Chinese infant formula sale

(Reuters) -British consumer goods maker Reckitt Benckiser Group Plc said on Saturday it was selling its infant formula and child nutrition (IFCN) business in China to investment firm Primavera Capital Group for an enterprise value of $2.2 billion.

Reckitt to sell China baby formula business for $2.2 billion

British consumer goods company Reckitt Benckiser Group has shortlisted bidders including Bain Capital, Carlyle Group and dairy producer Yili to submit binding offers for its Greater China infant formula business, sources said.

Reckitt shortlists bidders for $2bln Mead Johnson China business -sources

British consumer staples firm Reckitt Benckiser was a beneficiary of the cleaning and hygiene trends brought on by COVID.

Reckitt Benckiser Can Still Be A Solid Dividend Growth Stock

Lower demand for its cold and flu products, as more people stay home to avoid spreading Covid-19, send the shares down.

Strong Demand for Hygiene Products Boosts Lysol Maker Reckitt. The Stock is Down.

Reckitt Benckiser Group PLC (LON:RKT) shares slipped on Wednesday as the Dettol and Air Wick maker saw its revenue growth for the first quarter heavily dented by declines in its health and nutrition businesses, although the final growth figure remained in line with expectations. In its results for the first quarter of 2021, the FTSE 100 firm reported net revenues of £3.5bn, up 4.1% on a like-for-like (LFL) basis, with 28.5% LFL growth in its hygiene division offsetting declines in the health and nutrition segments of 13% and 7.4% respectively.

Reckitt Benckiser slips as health and nutrition declines heavily dent hygiene revenue growth

Cardinal Health

CVS Health

Novo Nordisk

In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer.

Hunting For Recession-Proof Bargains: 10 Picks As Prey

Cleaning products maker Reckitt Benckiser Group Plc said on Tuesday it would rebrand itself and be known simply as Reckitt, reflecting the latter's widespread usage.

Cleaning products maker Reckitt Benckiser tidies name, rebrands as simply Reckitt

Reckitt Benckiser Group PLC (LON:RB.) is mulling the sale of its infant formula business in Greater China, in a deal that could value the business at more than $2bn, Reuters reported, citing two people with knowledge of the matter.

Reckitt Benckiser mulls sale of infant formula business in Greater China - reports

British consumer goods company Reckitt Benckiser Group is considering selling its infant formula business in Greater China, in a deal that could value the business at more than $2 billion, two people with knowledge of the matter said.

Reckitt Benckiser considers over $2 billion sale of Mead Johnson Greater China: sources

Reckitt Benckiser delivered what was outlined in their transformation plan a year ago. The FCF conversion was strong, the productivity program is ahead of plan, investments were made to drive growth and the balance sheet was strengthened.

Reckitt Benckiser Is On Track For Great Long-Term Returns

Reckitt Benckiser: A Long Term Winner, Even After The Pandemic?

Automatic Data Processing

Intercontinental Exchange

The MS Global Franchise Fund (Trades, Portfolio), which is part of investment bank Morgan Stanley (NYSE:MS), disclosed its third-quarter portfolio earlier this week.

The Top 5 Trades of the MS Global Franchise Fund

British drugmaker Indivior Plc said on Monday it would "vigorously defend" against a 1.07 billion pound ($1.43 billion) legal claim from consumer good maker Reckitt Benckiser Group relating to their demerger agreement.

News for Reckitt Benckiser Group PLC Stock (RBGLY)